"10.1371_journal.pone.0142600","plos one","2015-11-10T00:00:00Z","Victor G Valcour; Serena S Spudich; Napapon Sailasuta; Nittaya Phanuphak; Sukalaya Lerdlum; James L K Fletcher; Eugene D M B Kroon; Linda L Jagodzinski; Isabel E Allen; Collin L Adams; Peeriya Prueksakaew; Bonnie M Slike; Joanna M Hellmuth; Jerome H Kim; Jintanat Ananworanich; SEARCH 010/RV 254 Study Group","Department of Neurology, University of California San Francisco, San Francisco, California, United States of America; Department of Neurology, Yale University, New Haven, Connecticut, United States of America; Huntington Medical Research Institutes, Pasadena, California, United States of America; South East Asia Research Collaboration with Hawaii, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; Department of Retrovirology, Armed Forces Research Institute of Medical Sciences, United States Component, Bangkok, Thailand; United States Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America; Department of Biostatistics and Epidemiology, University of California San Francisco, San Francisco, California, United States of America; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America","Conceived and designed the experiments: VGV SSS NP JHK JA. Performed the experiments: NP JLKF EDMBK PP JMH JA. Analyzed the data: VGV SSS JA IEA. Contributed reagents/materials/analysis tools: VGV SSS NS NP SL JLKF EDMBK LLJ IEA CLA PP BMS JMH JHK JA. Wrote the paper: VGV SSS NS NP SL JLKF EDMBK LLJ IEA CLA PP BMS JMH JHK JA.","Dr. Valcour has recently served as a consultant to ViiV Healthcare, who have supported antiretrovirals for this study but have not had input on the analyses or the manuscript. The authors also note that The Thai Government Pharmaceutical Organization (tenofovir, lamivudine, efavirenz), Gilead (Truvada, Atripla), Merck (Sustiva, Isentress), and ViiV Healthcare (Selzentry) provided antiretroviral therapy. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","11","Victor G Valcour","VGV",16,TRUE,5,6,4,15,TRUE,TRUE,TRUE,1,"16",TRUE
